Role of BMP family members during kidney development

International Journal of Developmental Biology

Volumn 43, Issue 5, 1999, Pages 405-411

  Godin, Robert E ^a   Robertson, Elizabeth J ^a   Dudley, Andrew T ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bone morphogenetic proteins; Kidney; Mouse

Indexed keywords

BONE MORPHOGENETIC PROTEIN; OSTEOGENIC PROTEIN 1;

ANIMAL TISSUE; CELL POPULATION; EMBRYO DEVELOPMENT; EPITHELIUM; KIDNEY DEVELOPMENT; MESENCHYME; MOUSE; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; URETER;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; KIDNEY; MESODERM; MICE; MORPHOGENESIS; NEPHRONS; TRANSFORMING GROWTH FACTOR BETA; WOLFFIAN DUCT;

ANIMALIA;

EID: 0032836114     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. ATTISANO, L., CARCAMO, J., VENTURA, F., WEIS, F.M.B, MASSAGUE, J. and WRANA, J.L. (1993). Identification of human activin and TGFB type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671-680.
2. COLES, H.S.R., BURNE, J.F. and RAFF, M.C. (1993). Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784.
3. DAVIES, J.A. (1996). Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta. Anat. 156: 187-201.
4. DEWULF, N., VERSCHUEREN, K., LONNOY, O., MOREN, A., GRIMSBY, S., VANDE SPIEGEL, K., MIYAZONO, K., HUYLEBROECK, D. and TEN DIJKE, P. (1995). Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136: 2652-2663.
5. DICK, A., RISAU, W. and DREXLER, H. (1998). Expression of Smad 1 and Smad 2 during embryogenesis suggests a role in organ development. Dev. Dynamics 211: 293-305.
6. DUDLEY, A.T. and ROBERTSON, E.J. (1997). Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev. Dynamics 208: 349-362.
7. DUDLEY A.T., GODIN, R.E and ROBERTSON, E.J (1999). Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev. 13: 1601-1613.
8. DUDLEY, A.T., LYONS, K.M. and ROBERTSON, E.J. (1995). A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9: 2795-2807.
9. DUNN, N.R., WINNIER, G.E., HARGETT, L.K., SCHRICK, J.J., FOGO, A.B. and HOGAN, B.L.M. (1997). Haploinsufficient phenotypes in BMP4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev. Biol. 188: 235-247
10. FEIJEN, A., GOUMANS, M.-J. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1994). Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins. Development 120: 3621-3637.
11. GODIN, R.E., TAKAESU, N., ROBERTSON, E.J. and DUDLEY, A.T. (1998). Regulation of Bmp7 expression during kidney development. Development 125: 3473-3432.
12. GREEN, E.L. and GREEN, M.C. (1942). The development of three manifestations of the short ear gene in the mouse. J. Morphol. 70: 1-19.
13. GREEN, M.C. (1968). Mechanism of the pleiotropic effects of the short ear mutant gene in the mouse. J. Exp. Zool. 167: 129-150.
14. IKEDA, T., TAKAHASHI, H., SUZUKI, A., UENO, N., YOKOSE, S., YAMAGUCHI, A. and YOSHIKI, S. (1996). Cloning of rat type I receptor cDNA for bone morphogenetic protein-2 and bone morphogenetic protein-4, and the localization compared with that of the ligands. Dev. Dynamics 206: 318-329.
15. IWASAKI, S., TSURUOKA, N., HATTORI, A., SATO, M., TSUJIMOTO, M. and KOHNO, M. (1995). Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein 2. J. Biol. Chem. 270: 5476-5482.
16. JONES, C.M. and SMITH J.C. (1998). Establishment of a BMP4 morphogen gradient by long range inhibition. Dev. Biol. 194: 12-17.
17. KING, J.A., MARKER, P.C., SEUNG, K.S. and KINGSLEY, D.M. (1994). BMP5 and the molecular, skeletal and soft tissue alterations in short ear mice. Dev. Biol. 166: 112-122.
18. KISPERT, A., VAINIO, S. and MCMAHON, A.P. (1998). Wnt4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development 125: 4225-4234.
19. KRETZSCHMAR, M. and MASSAGUE, J. (1998). Smads: mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 8: 103-111.
20. LUO, G., HOFMANN, C., BRONCKERS, A.L.J.J., SOHOCKI, M., BRADLEY, A. and KARSENTY, G. (1995). BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9: 2808-2820.
21. MEERSSEMAN, G., VERSCHUEREN, K., NELLES, L., BLUMENSTOCK, C., KRAFT, H., WUYTENS, G., REMACLE, J., KOZAK, C.A., TYLZANOWSKI, P., NIEHRS, C., and HUYLEBROECK, D. (1997). The C-terminal domain of mad like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation. Mech. Dev. 61: 127-140.
22. MENDELSOHN, C., BATOURINA, E., FUNG, S., GILBERT, T. and DODD, J. (1999). Stromal cells mediate retinoid-dependent functions essential for renal development. Development 126: 1139-1148.
23. ORR-URTREGER, A., GIVOL, D., YAYON, A., YARDEN, Y. and LONAI, P. (1991). Developmental expression of two murine fibroblast growth factor receptors, fig and bek. Development 113: 1419-1434.
24. PERANTONI, A.O., DOVE, L.F. and KARAVANOVA, I. (1995). Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc. Natl. Acad. Sci. USA 92: 4696-4700.
25. PINSON-HYINK, D., TUCKER, D.C., ST JOHN, P. T., LEARDKAMDKARN, V., ACCAVITTI, M. A., ABRASS, C.K. and ABRAHAMSON, D.R. (1996)Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys. Am. J. Physiol. 270: F886-899.
26. PISCIONE, T.D., YAGER, T.D., GUPTA, I.R., GRINFIELD, B., PEI, Y., ATTISANO, L., WRANA, J.L. and ROOSENBLUM, N.D. (1997). BMP2 and OP1 exert direct and opposite effects on renal branching morphogenesis. Am. J. Physiol. 273: F961-F975.
27. ROELEN, B.A.J., GOUMANS, M.-J., VAN ROOIJEN, M.A. and MUMMERY, C.L. (1997). Differential expression of BMP receptors in early mouse development. Int. J. Dev. Biol. 41: 541-549.
28. RUPPERT, R., HOFFMANN, E. and SEBALD, W. (1996). Human oone morphogenetic protein 2 contains a heparin binding site which modifies its biological activity. Eur. J. Biochem. 237: 295-302.
29. SAINIO, K., SUVANTO, P., DAVIES, J., WARTIOVAARA, J., WARTIOVARA, K., SAARMA, M., AMMAE, U., MENG, X., LINDAHL. M., PACHNIS, V. and SARIOLA, H. (1997). Glial cell line derived neurotrophic factor is required for bud initiation from the ureteric epithelium. Development 124: 4077-4087.
30. SARIOLA, H., HOLM, K. and HENKE-FAHLE, S. (1988). Early innervation of the metanephric kidney. Development 104: 589-599.
31. SIMON, M., MARESH, J.G., HARRIS, S.E., HERNANDEZ, J.D., ARAR, M., OLSON, M.S. and ABBOUD, H.E. (1999). Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am. J. Physiol. 276: F382-389.
32. SOLLOWAY, M.J. and ROBERTSON, E.J. (1999). Early embryonic lethality in BMP5;BMP7 double mutant mice suggests functional redundancy within the 6OA subgroup. Development 126: 1753-1768.
33. SOLLOWAY, M.J., DUDLEY, A.T., BIKOFF, E.K., LYONS, K.M., HOGAN, B.L. and ROBERTSON, E.J. (1998). Mice lacking BMP6function. Dev. Genet. 22: 321-339.
34. TSUCHIDA, K., MATHEWS, L.S. and VALE, W.W. (1993). Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc. Natl. Acad. Sci. USA. 90: 11242-11246.
35. VARLEY, J.E. and MAXWELL, G.D. (1996). BMP-2 and BMP-4, but not BMP-6, increase the number of adrenergic cells which develop in quail trunk neural crest cultures. Exp. Neurol. 140: 84-94.
36. VARLEY, J.E., MCPHERSON, C.E., ZOU, H., NISWANDER, L. and MAXWELL. G.D. (1998). Expression of a constitutively active type I BMP receptor using a retroviral vector promotes the development of adrenergic cells in neural crest cultures. Dev. Biol. 196: 107-118.
37. VARLEY, J.E., WEHBY, R.G., RUEGER, D.C. and MAXWELL, G.D. (1995). Number of adrenergic and islet-1 immunoreactive cells is increased in avian trunk neural crest cultures in the presence of human recombinant osteogen c protein-1. Dev. Dynamics 203: 434-447.
38. VUKICEVIC, S., BASIC, V., ROGIC, D., BASIC, N., SHIH, M.S., SHEPARD, A., JIN, D., DATTATREYAMURTY, B., JONES, W., DORAI, H., RYAN, S., GRIFFITHS, D., MALIAKAL, J., JELIC, M., PASTORCIC, M., STAVLJENIC, A. and SAMPATH, T.K. (1998). Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J. Clin. Invest. 102: 202-214.
39. VUKICEVIC, S., KOPP, J.B., LUYTEN, F.P. and SAMPATH, T.K. (1996). Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc. Natl. Acad. Sci. USA 93: 9021-9026.
40. VUKICEVIC, S., LATIN, V., CHEN, P., BATORSKY, R., REDDI, A.H. and SAMPATH, K. (1994). Localization of osteogenic protein-1 (Bone morphogenetic protein 7) during human embryonic development: high affinity binding to basement membranes. Biochem. Biophys. Res. Commun 198: 693-700.
41. WELLER, A., SOROKIN, L., ILLGREN, E.M. and EKBLOM, P. (1991). Development and growth of mouse embryonic kidney in organ culture and modulation of development by soluble growth factors. Dev. Biol. 144: 248-261.
42. WINNIER, G., BLESSING, M., LABOSKY, P.A. and HOGAN, B.L.M. (1995). Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9: 2105-2116
43. YANG, X., CASTILLA, L.H., XU, X., LI, C., GOTAY, J., WEINSTEIN, M., LIU, P.P. and DENG, C.-X. (1999). Angiogenesis defects and mesenchymal apoptosis in mice lacking smad 5. Development 126: 1571-1580.
44. ZHANG, H. and BRADLEY, A. (1996). Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122: 2977-2986.